Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Sage Therapeutics Inc has a consensus price target of $11.55 based on the ratings of 22 analysts. The high is $26 issued by Piper Sandler on October 30, 2024. The low is $4 issued by RBC Capital on November 21, 2024. The 3 most-recent analyst ratings were released by Scotiabank, Wedbush, and Canaccord Genuity on February 12, 2025, respectively. With an average price target of $8.67 between Scotiabank, Wedbush, and Canaccord Genuity, there's an implied 30.13% upside for Sage Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/30/2025 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | Hold → Hold | Get Alert |
04/25/2025 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | Hold → Hold | Get Alert |
02/12/2025 | Buy Now | 80.18% | Scotiabank | George Farmer39% | $14 → $12 | Maintains | Sector Outperform | Get Alert |
02/12/2025 | Buy Now | -9.91% | Wedbush | Laura Chico46% | $6 → $6 | Reiterates | Neutral → Neutral | Get Alert |
02/12/2025 | Buy Now | 20.12% | Canaccord Genuity | Sumant Kulkarni42% | $9 → $8 | Maintains | Hold | Get Alert |
02/12/2025 | Buy Now | 80.18% | HC Wainwright & Co. | Douglas Tsao51% | $14 → $12 | Reiterates | Neutral → Neutral | Get Alert |
02/12/2025 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | Hold → Hold | Get Alert |
01/02/2025 | Buy Now | 35.14% | Piper Sandler | David Amsellem77% | $26 → $9 | Maintains | Overweight | Get Alert |
12/16/2024 | Buy Now | -9.91% | Stifel | Paul Matteis44% | $10 → $6 | Maintains | Hold | Get Alert |
11/21/2024 | Buy Now | 35.14% | TD Cowen | Ritu Baral34% | $10 → $9 | Maintains | Hold | Get Alert |
11/21/2024 | Buy Now | -39.94% | RBC Capital | Brian Abrahams49% | $4 → $4 | Upgrade | Underperform → Sector Perform | Get Alert |
11/20/2024 | Buy Now | 110.21% | HC Wainwright & Co. | Douglas Tsao51% | $14 → $14 | Reiterates | Neutral → Neutral | Get Alert |
11/20/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
10/30/2024 | Buy Now | 110.21% | Scotiabank | George Farmer39% | $17 → $14 | Maintains | Sector Outperform | Get Alert |
10/30/2024 | Buy Now | 290.39% | Piper Sandler | Yasmeen Rahimi54% | $52 → $26 | Reiterates | Overweight → Overweight | Get Alert |
10/30/2024 | Buy Now | 20.12% | Oppenheimer | Jay Olson60% | $9 → $8 | Maintains | Perform | Get Alert |
10/30/2024 | Buy Now | 20.12% | Truist Securities | Joon Lee76% | $13 → $8 | Maintains | Hold | Get Alert |
10/30/2024 | Buy Now | 110.21% | HC Wainwright & Co. | Douglas Tsao51% | $25 → $14 | Maintains | Neutral | Get Alert |
10/30/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
10/17/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
10/10/2024 | Buy Now | — | Raymond James | Danielle Brill44% | — | Reinstates | → Market Perform | Get Alert |
10/09/2024 | Buy Now | -9.91% | B of A Securities | Tazeen Ahmad55% | $11 → $6 | Maintains | Underperform | Get Alert |
10/09/2024 | Buy Now | 20.12% | Wedbush | Laura Chico46% | $9 → $8 | Maintains | Neutral | Get Alert |
10/09/2024 | Buy Now | 35.14% | Baird | Joel Beatty67% | $13 → $9 | Maintains | Neutral | Get Alert |
10/09/2024 | Buy Now | 275.38% | HC Wainwright & Co. | Douglas Tsao51% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
10/08/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
10/04/2024 | Buy Now | -39.94% | RBC Capital | Brian Abrahams49% | $10 → $4 | Downgrade | Sector Perform → Underperform | Get Alert |
08/14/2024 | Buy Now | 95.2% | Truist Securities | Joon Lee76% | $18 → $13 | Maintains | Hold | Get Alert |
08/06/2024 | Buy Now | 50.15% | JP Morgan | Anupam Rama57% | $12 → $10 | Maintains | Neutral | Get Alert |
08/02/2024 | Buy Now | 275.38% | HC Wainwright & Co. | Douglas Tsao51% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
08/01/2024 | Buy Now | 680.78% | Piper Sandler | Yasmeen Rahimi54% | $70 → $52 | Maintains | Overweight | Get Alert |
08/01/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
07/30/2024 | Buy Now | 50.15% | TD Cowen | Ritu Baral34% | $16 → $10 | Downgrade | Buy → Hold | Get Alert |
07/26/2024 | Buy Now | 65.17% | Goldman Sachs | Salveen Richter54% | $19 → $11 | Maintains | Neutral | Get Alert |
07/25/2024 | Buy Now | 155.26% | Scotiabank | George Farmer39% | $19 → $17 | Maintains | Sector Outperform | Get Alert |
07/25/2024 | Buy Now | 80.18% | JP Morgan | Anupam Rama57% | $18 → $12 | Downgrade | Overweight → Neutral | Get Alert |
07/25/2024 | Buy Now | 95.2% | Baird | Joel Beatty67% | $15 → $13 | Maintains | Neutral | Get Alert |
07/25/2024 | Buy Now | 275.38% | HC Wainwright & Co. | Douglas Tsao51% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
07/24/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
07/19/2024 | Buy Now | 140.24% | Mizuho | Uy Ear64% | $18 → $16 | Maintains | Neutral | Get Alert |
07/12/2024 | Buy Now | 170.27% | JP Morgan | Anupam Rama57% | $23 → $18 | Maintains | Overweight | Get Alert |
07/02/2024 | Buy Now | 275.38% | HC Wainwright & Co. | Douglas Tsao51% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
06/28/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
06/20/2024 | Buy Now | 245.35% | JP Morgan | Anupam Rama57% | $28 → $23 | Maintains | Overweight | Get Alert |
06/12/2024 | Buy Now | 275.38% | HC Wainwright & Co. | Douglas Tsao51% | $25 → $25 | Reiterates | Neutral → Neutral | Get Alert |
06/11/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
06/11/2024 | Buy Now | 125.23% | Baird | Joel Beatty67% | $15 → $15 | Maintains | Neutral | Get Alert |
05/29/2024 | Buy Now | 20.12% | Citigroup | David Hoang42% | → $8 | Initiates | → Sell | Get Alert |
05/29/2024 | Buy Now | 125.23% | Baird | Joel Beatty67% | → $15 | Initiates | → Neutral | Get Alert |
05/01/2024 | Buy Now | 320.42% | JP Morgan | Anupam Rama57% | $29 → $28 | Maintains | Overweight | Get Alert |
04/26/2024 | Buy Now | 275.38% | HC Wainwright & Co. | Douglas Tsao51% | $28 → $25 | Maintains | Neutral | Get Alert |
04/26/2024 | Buy Now | 185.29% | Goldman Sachs | Salveen Richter54% | $28 → $19 | Maintains | Neutral | Get Alert |
04/26/2024 | Buy Now | 125.23% | RBC Capital | Brian Abrahams49% | $26 → $15 | Maintains | Sector Perform | Get Alert |
04/26/2024 | Buy Now | 170.27% | Truist Securities | Joon Lee76% | $22 → $18 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | 170.27% | Mizuho | Uy Ear64% | $20 → $18 | Maintains | Neutral | Get Alert |
04/26/2024 | Buy Now | 155.26% | Canaccord Genuity | Sumant Kulkarni42% | $21 → $17 | Maintains | Hold | Get Alert |
04/26/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
04/25/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
04/18/2024 | Buy Now | 185.29% | Scotiabank | George Farmer39% | $34 → $19 | Maintains | Sector Outperform | Get Alert |
04/18/2024 | Buy Now | 155.26% | Oppenheimer | Jay Olson60% | $25 → $17 | Maintains | Perform | Get Alert |
04/18/2024 | Buy Now | 140.24% | TD Cowen | Ritu Baral34% | $30 → $16 | Maintains | Buy | Get Alert |
04/18/2024 | Buy Now | — | Needham | Ami Fadia56% | — | Reiterates | → Hold | Get Alert |
04/17/2024 | Buy Now | 320.42% | HC Wainwright & Co. | Douglas Tsao51% | $28 → $28 | Reiterates | Neutral → Neutral | Get Alert |
04/17/2024 | Buy Now | 260.36% | Wedbush | Laura Chico46% | $24 → $24 | Reiterates | Neutral → Neutral | Get Alert |
04/17/2024 | Buy Now | 110.21% | B of A Securities | Tazeen Ahmad55% | $24 → $14 | Downgrade | Neutral → Underperform | Get Alert |
03/26/2024 | Buy Now | 335.44% | JP Morgan | Anupam Rama57% | $24 → $29 | Maintains | Overweight | Get Alert |
03/11/2024 | Buy Now | 290.39% | RBC Capital | Brian Abrahams49% | $26 → $26 | Reiterates | Sector Perform → Sector Perform | Get Alert |
02/28/2024 | Buy Now | 230.33% | Morgan Stanley | Vikram Purohit37% | $20 → $22 | Maintains | Equal-Weight | Get Alert |
02/15/2024 | Buy Now | 320.42% | HC Wainwright & Co. | Douglas Tsao51% | $25 → $28 | Maintains | Neutral | Get Alert |
02/15/2024 | Buy Now | 290.39% | RBC Capital | Brian Abrahams49% | $21 → $26 | Maintains | Sector Perform | Get Alert |
12/18/2023 | Buy Now | 200.3% | Stifel | Paul Matteis44% | $22 → $20 | Maintains | Hold | Get Alert |
12/12/2023 | Buy Now | 215.32% | Deutsche Bank | Neena Bitritto-Garg58% | → $21 | Initiates | → Hold | Get Alert |
11/08/2023 | Buy Now | 215.32% | RBC Capital | Brian Abrahams49% | $22 → $21 | Maintains | Sector Perform | Get Alert |
11/08/2023 | Buy Now | 230.33% | Wedbush | Laura Chico46% | $21 → $22 | Maintains | Neutral | Get Alert |
10/13/2023 | Buy Now | 275.38% | Goldman Sachs | Salveen Richter54% | $22 → $25 | Maintains | Neutral | Get Alert |
09/08/2023 | Buy Now | 260.36% | B of A Securities | Tazeen Ahmad55% | $25 → $24 | Maintains | Neutral | Get Alert |
09/07/2023 | Buy Now | 200.3% | Mizuho | Vamil Divan72% | $19 → $20 | Maintains | Neutral | Get Alert |
09/07/2023 | Buy Now | 230.33% | RBC Capital | Brian Abrahams49% | $25 → $22 | Maintains | Sector Perform | Get Alert |
08/09/2023 | Buy Now | 230.33% | Goldman Sachs | Salveen Richter54% | $75 → $22 | Maintains | Neutral | Get Alert |
08/09/2023 | Buy Now | 200.3% | Morgan Stanley | Vikram Purohit37% | $49 → $20 | Maintains | Equal-Weight | Get Alert |
08/08/2023 | Buy Now | 320.42% | TD Cowen | Ritu Baral34% | $105 → $28 | Maintains | Outperform | Get Alert |
08/08/2023 | Buy Now | 200.3% | Oppenheimer | Jay Olson60% | $24 → $20 | Maintains | Perform | Get Alert |
08/08/2023 | Buy Now | 275.38% | RBC Capital | Brian Abrahams49% | → $25 | Reiterates | Sector Perform → Sector Perform | Get Alert |
08/08/2023 | Buy Now | 200.3% | Truist Securities | Joon Lee76% | $40 → $20 | Maintains | Hold | Get Alert |
08/08/2023 | Buy Now | 185.29% | Mizuho | Vamil Divan72% | $45 → $19 | Maintains | Neutral | Get Alert |
08/08/2023 | Buy Now | 230.33% | Goldman Sachs | Salveen Richter54% | → $22 | Downgrade | Buy → Neutral | Get Alert |
08/08/2023 | Buy Now | 215.32% | Canaccord Genuity | Sumant Kulkarni42% | $64 → $21 | Downgrade | Buy → Hold | Get Alert |
08/08/2023 | Buy Now | — | Needham | Ami Fadia56% | — | Downgrade | Buy → Hold | Get Alert |
08/08/2023 | Buy Now | 305.41% | HC Wainwright & Co. | Douglas Tsao51% | $50 → $27 | Maintains | Neutral | Get Alert |
08/07/2023 | Buy Now | 230.33% | Stifel | Paul Matteis44% | $60 → $22 | Downgrade | Buy → Hold | Get Alert |
08/07/2023 | Buy Now | 230.33% | Wedbush | Laura Chico46% | → $22 | Downgrade | Outperform → Neutral | Get Alert |
08/07/2023 | Buy Now | 650.75% | HC Wainwright & Co. | Douglas Tsao51% | → $50 | Reiterates | Neutral → Neutral | Get Alert |
08/07/2023 | Buy Now | 275.38% | RBC Capital | Brian Abrahams49% | $71 → $25 | Downgrade | Outperform → Sector Perform | Get Alert |
08/07/2023 | Buy Now | — | Oppenheimer | Jay Olson60% | — | Downgrade | Outperform → Perform | Get Alert |
08/07/2023 | Buy Now | 951.05% | Needham | Ami Fadia56% | → $70 | Reiterates | Buy → Buy | Get Alert |
08/03/2023 | Buy Now | 635.74% | Morgan Stanley | Vikram Purohit37% | $49 → $49 | Maintains | Equal-Weight | Get Alert |
07/27/2023 | Buy Now | 815.92% | Scotiabank | George Farmer39% | → $61 | Initiates | → Sector Outperform | Get Alert |
05/23/2023 | Buy Now | 815.92% | B of A Securities | Tazeen Ahmad55% | $56 → $61 | Maintains | Buy | Get Alert |
05/23/2023 | Buy Now | 650.75% | HC Wainwright & Co. | Douglas Tsao51% | → $50 | Reiterates | Neutral → Neutral | Get Alert |
05/09/2023 | Buy Now | 635.74% | Morgan Stanley | Vikram Purohit37% | $50 → $49 | Maintains | Equal-Weight | Get Alert |
The latest price target for Sage Therapeutics (NASDAQ:SAGE) was reported by Needham on April 30, 2025. The analyst firm set a price target for $0.00 expecting SAGE to fall to within 12 months (a possible -100.00% downside). 49 analyst firms have reported ratings in the last year.
The latest analyst rating for Sage Therapeutics (NASDAQ:SAGE) was provided by Needham, and Sage Therapeutics reiterated their hold rating.
The last upgrade for Sage Therapeutics Inc happened on November 21, 2024 when RBC Capital raised their price target to $4. RBC Capital previously had an underperform for Sage Therapeutics Inc.
The last downgrade for Sage Therapeutics Inc happened on October 4, 2024 when RBC Capital changed their price target from $10 to $4 for Sage Therapeutics Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sage Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sage Therapeutics was filed on April 30, 2025 so you should expect the next rating to be made available sometime around April 30, 2026.
While ratings are subjective and will change, the latest Sage Therapeutics (SAGE) rating was a reiterated with a price target of $0.00 to $0.00. The current price Sage Therapeutics (SAGE) is trading at is $6.66, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.